OFM
Omega Fund Management Portfolio holdings
AUM
$154M
This Quarter Return
+20.53%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$160M
AUM Growth
+$160M
(+4.2%)
Cap. Flow
-$7.72M
Cap. Flow
% of AUM
-4.82%
Top 10 Holdings %
Top 10 Hldgs %
99.56%
Holding
11
New
–
Increased
–
Reduced
3
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
FibroGen
FGEN
|
$5.98M |
| 2 |
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
|
$1.67M |
| 3 |
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
|
$71.8K |
Sector Composition
| 1 | Healthcare | 76.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRTK
1
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $62.7M | 39.11% | 2,600,410 | – | – |
|
|
JUNO
2
DELISTED
Juno Therapeutics, Inc.
JUNO
| $36.8M | 22.93% | 1,229,512 | – | – |
|
|
3
FibroGen
FGEN
$47.8M
| $20.3M | 12.65% | 627,492 -185,000 | -23% | -$5.98M |
|
|
NBRV
4
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $11.9M | 7.45% | 1,139,035 -6,855 | -0.6% | -$71.8K |
|
|
JNCE
5
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $8.13M | 5.07% | 579,650 | – | – |
|
|
PVLA
6
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $6.92M | 4.32% | 1,367,253 -330,131 | -19% | -$1.67M |
|
|
EGLT
7
DELISTED
Egalet Corporation
EGLT
| $6.85M | 4.27% | 2,889,926 | – | – |
|
8
Cidara Therapeutics
CDTX
$1.66B
| $3.34M | 2.08% | 444,965 | – | – |
|
|
CBAY
9
DELISTED
Cymabay Therapeutics
CBAY
| $1.74M | 1.08% | 301,477 | – | – |
|
10
ESSA Pharma
EPIX
$11.4M
| $933K | 0.58% | 1,696,969 | – | – |
|
|
DRNA
11
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $708K | 0.44% | 223,457 | – | – |
|